Jason Riggs, AuD, PhD

Regeneron Pharmaceuticals, Inc., United States

Presentation(s):

• Preliminary Efficacy and Safety of DB-OTO Gene Therapy in Pediatric Patients With Profound Hearing Loss

  Sunday, September 29, 2024
  3:12 PM – 3:18 PM EDT

  Disclosure information not submitted.